Angiogenesis gene therapy to rescue ischaemic tissues: Achievements and future directions

British Journal of Pharmacology

Volumn 133, Issue 7, 2001, Pages 951-958

  Emanueli, Costanza ^a   Madeddu, Paolo ^a,b  

^a NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Angiogenesis; Endothelium; Gene therapy; Growth factors; Ischaemia; Viral vectors

Indexed keywords

COMPLEMENTARY DNA; GROWTH FACTOR; VASCULOTROPIN; VIRUS VECTOR;

ANGIOGENESIS; ARTERY ENDOTHELIUM; ARTERY OCCLUSION; DEVELOPED COUNTRY; GENE THERAPY; GENE TRANSFER; HOST RESISTANCE; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; ISCHEMIA; PRIORITY JOURNAL; REVIEW; TISSUE PERFUSION; TISSUE REPAIR; VASCULARIZATION;

EID: 0034883615     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704155     Document Type: Review

References (69)

1. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb
2. Bone marrow origin of endothelial progenitor cells responsible for post-natal vasculogenesis in physiological and pathological neovascularization
3. Isolation of putative progenitor endothelial cells for angiogenesis
4. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor
5. Effects of aFGF on normal and ischemic myocardium
6. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
7. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
8. Molecular mechanisms of blood vessel formation
9. Mechanisms of angiogenesis and arteriogenesis
10. Imparied myocardial angiogenesis and ischemic myocardiopathy in mice lacking the vascular growth factor isoforms VEGF164 and VEGF188
11. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization
12. Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats
13. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/-mice
14. Phase I study of direct administration of a replication deficient adenovirus vector containing E. choli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the pro-drug 5-fluorocytosine
15. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
16. Selective uptake and sustained expression of AAV vectors following subcutaneous delivery
17. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia
18. Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer
19. Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle
20. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo
21. Clinical applications of angiogenic growth factors and their inhibitors
22. The biology of vascular endothelial growth factor
23. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina
24. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of the immune response
25. 2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats
26. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia
27. Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use
28. Signaling vascular morphogenesis and maintenance
29. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect
30. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
31. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF 165 in patient with ischemic limb
32. Trasplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization
33. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics
34. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study
35. Transgenic mice model of ocular neovascularization driven by vascular endothelial growth factor (VEGF) overexpression
36. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury
37. VEGF gene delivery to myocardium. Deleterious effects of unregulated expression
38. Human gene therapy. The good, the bad, and the ugly
39. Gene therapy for myocardial angiogenesis
40. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
41. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner
42. Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors
43. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
44. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointima hyperplasia
45. The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers
46. Enhanced revascularization of the ischemic limb by angiogenic therapy
47. Ang II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone
48. Mechanism of angiogenesis
49. Vasculogenesis
50. Age-dependent impairment of angiogenesis
51. Rescue of diabetes related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
52. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA
53. Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart
54. Coronary collateral development: Concepts and hypotheses
55. Molecular mechanisms of coronary vessel growth
56. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice
57. The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: First clinical results
58. 2 homeostasis
59. Augmentation of postnatal neovascularization with autologous bone marrow transplantation
60. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb
61. Clinical trials in coronary angiogenesis: Issues, problems, consensus: An expert panel summary
62. Increased vascularization in mice overexpressing angiopoietin-1
63. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo
64. Upregulation of bradykinin B1-receptor expression after myocardial infarction
65. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene
66. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease
67. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor. The case for paracrine amplification of angiogenesis
68. Angiogenesis in ischemic heart disease
69. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia